Embedded Files
Investing in ASX 200 stocks is a favored choice among many investors. When these stocks go ex-dividend, it's not just a routine event; it's a significant occurrence. This is because it signals the imminent arrival of dividends for investors, which is always a reason for cheer. However, it's also noteworthy for the usual drop in share prices associated with ex-dividend trading.
So, what exactly does it mean when an ASX 200 stock trades ex-dividend? Let's clarify. The ex-dividend date is the day when prospective investors are effectively excluded from receiving the upcoming dividend. In simple terms, if you own the shares before the ex-dividend date, you're in line to receive the dividend payment. But if you acquire them on or after the ex-dividend date, you'll miss out on the dividend.
The consequence of this is a visible dip in the company's share price. This drop mirrors the perceived loss of value for investors who won't receive the dividend. In this article, we'll explore three ASX 200 stocks set to go ex-dividend next week.
Champion Iron, an ASX 200 mining stock, recently disclosed its results for the six months ending on September 30, 2023. They announced an upcoming interim dividend of 10 Canadian cents per share. While the final Australian dollar equivalent is pending, this translates to approximately 11 Australian cents per share at current exchange rates.
Champion Iron shares are slated to go ex-dividend on Monday, November 6. This means today is the last opportunity to purchase shares and qualify for this dividend. Shareholders can anticipate receiving the dividend on November 28. At present, Champion Iron shares boast a dividend yield of 2.08%.
Next up is ResMed, an ASX 200 healthcare stock that pays out quarterly dividends. This is due to its primary listing in the United States, where quarterly dividends are customary. The next dividend from ResMed is scheduled for December 14. However, the ex-dividend date is set for November 8.
The forthcoming dividend will be 4.8 US cents per share, the same as the previous quarter. While the final Australian dollar equivalent is yet to be confirmed, it is anticipated to be around 7.5 Australian cents per share at current exchange rates. Currently, ResMed shares offer a dividend yield of 1.19%.
Lastly, we have CSR, an ASX 200 building products stock, which recently reported its latest half-year earnings. Despite a 5% increase in revenues, net profits after tax (NPAT) witnessed an 11.5% decline. Consequently, an interim dividend of 15 cents per share, fully franked, was declared. This is a reduction from the 16.5 cents per share that investors received for the same period last year.
CSR shares are poised to go ex-dividend for this upcoming payment on November 7, with the payment date set for December 7. Presently, CSR shares offer a dividend yield of 6.17%.
Conclusion
Conclusion
In summary, when ASX 200 stocks trade ex-dividend, it's a moment of great anticipation for investors. While the share price typically experiences a dip, the promise of receiving a dividend is cause for celebration among those who have made wise investments.
Page updated
Google Sites
Report abuse